at 9:05 AM
January 31, 2013
The days of monolithic, proprietary software systems are waning. As the
U.S. economy struggles to rebound, businesses — including major global
pharmaceutical companies — are looking for every advantage and cost
savings they can find. It is no surprise, then, that more and more
pharmas are looking to open source technology as a means ...
at 3:38 PM
January 3, 2013
Though lawmakers lately have been grappling with the so-called “fiscal cliff,” we can’t forget about the Affordable Care Act (ACA) and its impact on pharmaceutical companies. Originally published on pharmaphorum.com, Doug Weinbrenner discusses the US health system following Obama’s re-election, and looks at what it means for pharma.
at 1:00 PM
January 18, 2012
This topic comes up a lot around my agency: How do you define DTC? Of course, on the surface, DTC in the context of pharma marketing stands for "direct-to-consumer." Its roots likely go back to when FDA first approved the marketing of prescription products to U.S.consumers in the 1980's....
Wendy W. Blackburn
at 10:15 AM
May 6, 2011
Last week, FDA announced it would conduct research to better understand how DTC information is presented on branded websites and how it influences consumers' perception and understanding.
They're sponsoring three studies to examine how these website elements influence consumer understanding of product benefits and risks: Risk information on branded sites - including how ...
Wendy W. Blackburn
at 7:00 AM
January 6, 2011
Rohit Bhargava recently wrote a good post on his blog that he could have titled "What to Expect When You're Expecting," .... expecting social media guidance from FDA, that is.
The post is a solid interpretation of the FDA's recently-released “Strategic Priorities: 2011 - 2015″ document, i.e., what the FDA ...